Cargando…
PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27(Kip1) axis
BACKGROUND: Altered glucose metabolism endows tumor cells with metabolic flexibility for biosynthesis requirements. Phosphoenolpyruvate carboxykinase 1 (PCK1), a key enzyme in the gluconeogenesis pathway, is downregulated in hepatocellular carcinoma (HCC) and predicts poor prognosis. Overexpression...
Autores principales: | Tuo, Lin, Xiang, Jin, Pan, Xuanming, Hu, Jieli, Tang, Hua, Liang, Li, Xia, Jie, Hu, Yuan, Zhang, Wenlu, Huang, Ailong, Wang, Kai, Tang, Ni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360696/ https://www.ncbi.nlm.nih.gov/pubmed/30717766 http://dx.doi.org/10.1186/s13046-019-1029-y |
Ejemplares similares
-
PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
por: Tuo, Lin, et al.
Publicado: (2018) -
Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice
por: Ye, Qian, et al.
Publicado: (2023) -
The AMPK/p27(Kip1) Axis Regulates Autophagy/Apoptosis Decisions in Aged Skeletal Muscle Stem Cells
por: White, James P., et al.
Publicado: (2018) -
O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis
por: Liu, Rui, et al.
Publicado: (2021) -
Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq
por: Xiang, Jin, et al.
Publicado: (2019)